EV/EBITDA
0.32
0.000.00%
Thu, 06 Feb 2025 14:30:00 GMT
Summary
- As of February 7, 2025, ONCT EV/EBITDA is 0.32, unchanged from the previous trading day.
- Over the past year, ONCT EV/EBITDA has increased by +0.85 (+160.38%).
- ONCT EV/EBITDA is now -97.29% below its all-time high of 11.81.
Performance
ONCT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ONCT EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | 0.0% | 0.0% | 0.0% |
1 m1 month | 0.0% | 0.0% | 0.0% |
3 m3 months | +28.0% | -26.6% | -60.4% |
6 m6 months | +223.1% | -214.2% | -90.3% |
ytdytd | 0.0% | 0.0% | 0.0% |
1 y1 year | +160.4% | -151.4% | -94.5% |
5 y5 years | +114.7% | -128.0% | -99.3% |
ONCT EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | 0.32 | at low | |
3 m | 3-month | 0.32 | at high | 0.25 | +28.0% |
6 m | 6-month | 0.32 | at high | -0.27 | +218.5% |
1 y | 1-year | 0.32 | at high | -0.62 | +151.6% |
3 y | 3-year | 1.35 | -76.3% | -0.84 | +138.1% |
5 y | 5-year | 1.35 | -76.3% | -18.80 | +101.7% |
alltime | all time | 11.81 | -97.3% | -21.68 | +101.5% |
Oncternal Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | 0.32(0.0%) |
2024 | 0.32(-152.5%) |
2023 | -0.61(+35.6%) |
2022 | -0.45(-34.8%) |
2021 | -0.69(-90.1%) |
2020 | -6.98(+217.3%) |
2019 | -2.20(-1016.7%) |
2018 | 0.24(-102.8%) |
2017 | -8.43(+190.7%) |
2016 | -2.90(-24.9%) |
2015 | -3.86(+38.4%) |
Date | Value |
---|---|
2014 | -2.79(+34.8%) |
2013 | -2.07(-53.1%) |
2012 | -4.41(+6.0%) |
2011 | -4.16(-188.1%) |
2010 | 4.72(-288.0%) |
2009 | -2.51(-77.8%) |
2008 | -11.29(+9.7%) |
2007 | -10.29(-21.1%) |
2006 | -13.04(+214.2%) |
2005 | -4.15(-64.2%) |
2004 | -11.59 |
FAQ
- What is Oncternal Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Oncternal Therapeutics?
- What is ONCT EV/EBITDA year-to-date change?
- What is Oncternal Therapeutics EV/EBITDA year-on-year change?
What is Oncternal Therapeutics EV/EBITDA?
The current EV/EBITDA of ONCT is 0.32
What is the all time high EV/EBITDA for Oncternal Therapeutics?
Oncternal Therapeutics all-time high EV/EBITDA is 11.81
What is ONCT EV/EBITDA year-to-date change?
Oncternal Therapeutics EV/EBITDA has changed by 0.00 (0.00%) since the beginning of the year
What is Oncternal Therapeutics EV/EBITDA year-on-year change?
Over the past year, ONCT EV/EBITDA has changed by +0.85 (+160.38%)